Urgent.News

What's breaking now, across thousands of outlets.

Science

Biomarkers identified for cytokine release syndrome risk after CAR T-cell therapy

For patients with autoimmune disease, higher baseline B-cell counts and systemic inflammation are associated with development of cytokine release syndrome (CRS) after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the November issue of The Lancet Rheumatology.

Biomarkers identified for cytokine release syndrome risk after CAR T-cell therapy

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Science

Biodiversity is a priority for European municipalities

As urbanization spreads worldwide, the loss and fragmentation of habitats are driving the global decline in biodiversity. At the same time, urban green spaces like parks, meadows and forests have the potential to contribute significantly to biodiversity conservation at the local and regional levels.

More from Monday 26 October →